Literature DB >> 29176392

Expanding the Use of Organs From Hepatitis C-Viremic Donors: The Evidence Continues to Build.

Courtenay M Holscher1, Christine M Durand2, Niraj M Desai1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29176392      PMCID： PMC5860943          DOI： 10.1097/TP.0000000000002032

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  9 in total

1.  Utilization of hepatitis C virus RNA-positive donor liver for transplant to hepatitis C virus RNA-negative recipient.

Authors:  Behnam Saberi; James P Hamilton; Christine M Durand; Zhiping Li; Benjamin Philosophe; Andrew M Cameron; Mark S Sulkowski; Ahmet Gurakar
Journal:  Liver Transpl       Date:  2018-01       Impact factor: 5.799

2.  Trial of Transplantation of HCV-Infected Kidneys into Uninfected Recipients.

Authors:  David S Goldberg; Peter L Abt; Emily A Blumberg; Vivianna M Van Deerlin; Matthew Levine; K Rajender Reddy; Roy D Bloom; Susanna M Nazarian; Deirdre Sawinski; Paige Porrett; Ali Naji; Richard Hasz; Lawrence Suplee; Jennifer Trofe-Clark; Anna Sicilia; Maureen McCauley; Midhat Farooqi; Caren Gentile; Jennifer Smith; Peter P Reese
Journal:  N Engl J Med       Date:  2017-04-30       Impact factor: 91.245

3.  Successful treatment of donor-derived hepatitis C infection in a lung transplant recipient.

Authors:  Nicole Theodoropoulos; Bryan A Whitson; Stanley I Martin; Stephanie Pouch; Amy Pope-Harman
Journal:  Transpl Infect Dis       Date:  2017-02-22       Impact factor: 2.228

4.  Use of Organs From Hepatitis C Virus-Positive Donors for Uninfected Recipients: A Potential Cost-Effective Approach to Save Lives?

Authors:  Patrick B Trotter; Dominic M Summers; Ines Ushiro-Lumb; Matthew Robb; J Andrew Bradley; James Powell; Christopher J E Watson; James Neuberger
Journal:  Transplantation       Date:  2018-04       Impact factor: 4.939

5.  Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012.

Authors:  Anil G Suryaprasad; Jianglan Z White; Fujie Xu; Beth-Ann Eichler; Janet Hamilton; Ami Patel; Shadia Bel Hamdounia; Daniel R Church; Kerri Barton; Chardé Fisher; Kathryn Macomber; Marisa Stanley; Sheila M Guilfoyle; Kristin Sweet; Stephen Liu; Kashif Iqbal; Rania Tohme; Umid Sharapov; Benjamin A Kupronis; John W Ward; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2014-08-11       Impact factor: 9.079

6.  The American Society of Transplantation Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ Transplantation.

Authors:  J Levitsky; R N Formica; R D Bloom; M Charlton; M Curry; J Friedewald; J Friedman; D Goldberg; S Hall; M Ison; T Kaiser; D Klassen; G Klintmalm; J Kobashigawa; A Liapakis; K O'Conner; P Reese; D Stewart; N Terrault; N Theodoropoulos; J Trotter; E Verna; M Volk
Journal:  Am J Transplant       Date:  2017-07-01       Impact factor: 8.086

7.  Five-year follow-up of hepatitis C-naïve heart transplant recipients who received hepatitis C-positive donor hearts.

Authors:  G S Gudmundsson; K Malinowska; J A Robinson; B A Pisani; J C Mendez; B K Foy; G M Mullen
Journal:  Transplant Proc       Date:  2003-06       Impact factor: 1.066

8.  The OPTN Deceased Donor Potential Study: Implications for Policy and Practice.

Authors:  D K Klassen; L B Edwards; D E Stewart; A K Glazier; J P Orlowski; C L Berg
Journal:  Am J Transplant       Date:  2016-03-10       Impact factor: 8.086

9.  Cost-effectiveness of elbasvir/grazoprevir use in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and chronic kidney disease in the United States.

Authors:  E Elbasha; W Greaves; D Roth; C Nwankwo
Journal:  J Viral Hepat       Date:  2016-12-13       Impact factor: 3.517
  9 in total
  2 in total

1.  High multiplicity infection following transplantation of hepatitis C virus-positive organs.

Authors:  Muhammad N Zahid; Shuyi Wang; Gerald H Learn; Peter L Abt; Emily A Blumberg; Peter P Reese; David S Goldberg; George M Shaw; Katharine J Bar
Journal:  J Clin Invest       Date:  2019-05-21       Impact factor: 14.808

2.  Changes in Utilization and Discard of HCV Antibody-Positive Deceased Donor Kidneys in the Era of Direct-Acting Antiviral Therapy.

Authors:  Mary G Bowring; Lauren M Kucirka; Allan B Massie; Tanveen Ishaque; Sunjae Bae; Ashton A Shaffer; Jacqueline Garonzik Wang; Mark Sulkowski; Niraj Desai; Dorry L Segev; Christine M Durand
Journal:  Transplantation       Date:  2018-12       Impact factor: 4.939
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.